Drugs / Humalog Mix 75/25
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03320031 Background | Jun 2017 → Dec 2019 | type 2 diabetes mellitus | Yanbing Li | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Humalog Mix 75/25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03320031 ↗ |
| Route | Subcutaneous | “Administer subcutaneous premixed insulin twice a day.” NCT03320031 ↗ |